{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:06Z","timestamp":1790208006261,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Bodil and Magne\u00b4s Cancer Research Fund, Oslo, Norway","award":["2017"],"award-info":[{"award-number":["2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10549-018-4927-3","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T07:56:55Z","timestamp":1534838215000},"page":"339-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer"],"prefix":"10.1007","volume":"172","author":[{"given":"Vahid","family":"Bemanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Christopher","family":"Noone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torill","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Touma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Vetvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"S\u00f8derberg-Naucler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Christoffer","family":"Lindstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Rashida","family":"Bukholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vessela N.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-3856","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"issue":"3","key":"4927_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molonc.2010.04.006","volume":"4","author":"F Podo","year":"2010","unstructured":"Podo F, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, Postma GJ, Schneiderhan-Marra N, Santoro F, Wouters H, Russnes HG, Sorlie T, Tagliabue E, Borresen-Dale AL, Consortium F (2010) Triple-negative breast cancer: present challenges and new perspectives. Mol Oncol 4(3):209\u2013229. https:\/\/doi.org\/10.1016\/j.molonc.2010.04.006","journal-title":"Mol Oncol"},{"issue":"2","key":"4927_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-016-4059-6","volume":"161","author":"X Li","year":"2017","unstructured":"Li X, Yang J, Peng L, Sahin AA, Huo L, Ward KC, O\u2019Regan R, Torres MA, Meisel JL (2017) Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast Cancer Res Treat 161(2):279\u2013287. https:\/\/doi.org\/10.1007\/s10549-016-4059-6","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4927_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.18632\/oncotarget.12284","volume":"8","author":"H Yao","year":"2017","unstructured":"Yao H, He G, Yan S, Chen C, Song L, Rosol TJ, Deng X (2017) Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget 8(1):1913\u20131924. https:\/\/doi.org\/10.18632\/oncotarget.12284","journal-title":"Oncotarget"},{"issue":"20","key":"4927_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938\u20131948. https:\/\/doi.org\/10.1056\/NEJMra1001389","journal-title":"N Engl J Med"},{"issue":"6797","key":"4927_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752. https:\/\/doi.org\/10.1038\/35021093","journal-title":"Nature"},{"issue":"23","key":"4927_CR6","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1158\/1078-0432.CCR-13-0915","volume":"19","author":"NC Turner","year":"2013","unstructured":"Turner NC, Reis-Filho JS (2013) Tackling the diversity of triple-negative breast cancer. Clin Cancer Res 19(23):6380\u20136388. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0915","journal-title":"Clin Cancer Res"},{"issue":"7403","key":"4927_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Group M, Langerod A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Borresen-Dale AL, Brenton JD, Tavare S, Caldas C, Aparicio S (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403):346\u2013352. https:\/\/doi.org\/10.1038\/nature10983","journal-title":"Nature"},{"issue":"7","key":"4927_CR8","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121(7):2750\u20132767. https:\/\/doi.org\/10.1172\/JCI45014","journal-title":"J Clin Invest"},{"issue":"29","key":"4927_CR9","doi-asserted-by":"publisher","first-page":"46482","DOI":"10.18632\/oncotarget.10208","volume":"7","author":"C Wang","year":"2016","unstructured":"Wang C, Pan B, Zhu H, Zhou Y, Mao F, Lin Y, Xu Q, Sun Q (2016) Prognostic value of androgen receptor in triple negative breast cancer: a meta-analysis. Oncotarget 7(29):46482\u201346491. https:\/\/doi.org\/10.18632\/oncotarget.10208","journal-title":"Oncotarget"},{"issue":"5","key":"4927_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/annonc\/mdw067","volume":"27","author":"H Bonnefoi","year":"2016","unstructured":"Bonnefoi H, Grellety T, Tredan O, Saghatchian M, Dalenc F, Mailliez A, L\u2019Haridon T, Cottu P, Abadie-Lacourtoisie S, You B, Mousseau M, Dauba J, Del Piano F, Desmoulins I, Coussy F, Madranges N, Grenier J, Bidard FC, Proudhon C, MacGrogan G, Orsini C, Pulido M, Goncalves A (2016) A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1). Ann Oncol 27(5):812\u2013818. https:\/\/doi.org\/10.1093\/annonc\/mdw067","journal-title":"Ann Oncol"},{"key":"4927_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jsbmb.2012.08.007","volume":"133","author":"KM McNamara","year":"2013","unstructured":"McNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H (2013) Androgen receptor in triple negative breast cancer. J Steroid Biochem Mol Biol 133:66\u201376. https:\/\/doi.org\/10.1016\/j.jsbmb.2012.08.007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4927_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32454-0","author":"C Denkert","year":"2016","unstructured":"Denkert C, Liedtke C, Tutt A, von Minckwitz G (2016) Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(16)32454-0","journal-title":"Lancet"},{"issue":"2","key":"4927_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10549-016-3746-7","volume":"156","author":"MC Rangel","year":"2016","unstructured":"Rangel MC, Bertolette D, Castro NP, Klauzinska M, Cuttitta F, Salomon DS (2016) Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer. Breast Cancer Res Treat 156(2):211\u2013226. https:\/\/doi.org\/10.1007\/s10549-016-3746-7","journal-title":"Breast Cancer Res Treat"},{"issue":"37","key":"4927_CR14","doi-asserted-by":"publisher","first-page":"60712","DOI":"10.18632\/oncotarget.10858","volume":"7","author":"D Massihnia","year":"2016","unstructured":"Massihnia D, Galvano A, Fanale D, Perez A, Castiglia M, Incorvaia L, Listi A, Rizzo S, Cicero G, Bazan V, Castorina S, Russo A (2016) Triple negative breast cancer: shedding light onto the role of pi3k\/akt\/mtor pathway. Oncotarget 7(37):60712\u201360722. https:\/\/doi.org\/10.18632\/oncotarget.10858","journal-title":"Oncotarget"},{"issue":"10","key":"4927_CR15","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/cam4.833","volume":"5","author":"JG Habib","year":"2016","unstructured":"Habib JG, O\u2019Shaughnessy JA (2016) The hedgehog pathway in triple-negative breast cancer. Cancer Med 5(10):2989\u20133006. https:\/\/doi.org\/10.1002\/cam4.833","journal-title":"Cancer Med"},{"issue":"4","key":"4927_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1158\/1078-0432.CCR-13-0583","volume":"20","author":"IA Mayer","year":"2014","unstructured":"Mayer IA, Abramson VG, Lehmann BD, Pietenpol JA (2014) New strategies for triple-negative breast cancer-deciphering the heterogeneity. Clin Cancer Res 20(4):782\u2013790. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0583","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4927_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cncr.28914","volume":"121","author":"VG Abramson","year":"2015","unstructured":"Abramson VG, Lehmann BD, Ballinger TJ, Pietenpol JA (2015) Subtyping of triple-negative breast cancer: implications for therapy. Cancer 121(1):8\u201316. https:\/\/doi.org\/10.1002\/cncr.28914","journal-title":"Cancer"},{"issue":"11","key":"4927_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13(11):674\u2013690. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"4927_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1309\/AJCPWDEQYCYC92JQ","volume":"144","author":"S Roy-Chowdhuri","year":"2015","unstructured":"Roy-Chowdhuri S, de Melo Gagliato D, Routbort MJ, Patel KP, Singh RR, Broaddus R, Lazar AJ, Sahin A, Alvarez RH, Moulder S, Wheler JJ, Janku F, Gonzalez-Angulo AM, Chavez-MacGregor M, Valero V, Ueno NT, Mills G, Mendelsohn J, Yao H, Aldape K, Luthra R, Meric-Bernstam F (2015) Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing. Am J Clin Pathol 144(5):713\u2013721. https:\/\/doi.org\/10.1309\/AJCPWDEQYCYC92JQ","journal-title":"Am J Clin Pathol"},{"issue":"7403","key":"4927_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V, McPherson A, Shumansky K, Crisan A, Giuliany R, Heravi-Moussavi A, Rosner J, Lai D, Birol I, Varhol R, Tam A, Dhalla N, Zeng T, Ma K, Chan SK, Griffith M, Moradian A, Cheng SW, Morin GB, Watson P, Gelmon K, Chia S, Chin SF, Curtis C, Rueda OM, Pharoah PD, Damaraju S, Mackey J, Hoon K, Harkins T, Tadigotla V, Sigaroudinia M, Gascard P, Tlsty T, Costello JF, Meyer IM, Eaves CJ, Wasserman WW, Jones S, Huntsman D, Hirst M, Caldas C, Marra MA, Aparicio S (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486(7403):395\u2013399. https:\/\/doi.org\/10.1038\/nature10933","journal-title":"Nature"},{"issue":"7418","key":"4927_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas N","year":"2012","unstructured":"Cancer Genome Atlas N (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61\u201370. https:\/\/doi.org\/10.1038\/nature11412","journal-title":"Nature"},{"issue":"14","key":"4927_CR22","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/onc.2009.489","volume":"29","author":"N Turner","year":"2010","unstructured":"Turner N, Lambros MB, Horlings HM, Pearson A, Sharpe R, Natrajan R, Geyer FC, van Kouwenhove M, Kreike B, Mackay A, Ashworth A, van de Vijver MJ, Reis-Filho JS (2010) Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene 29(14):2013\u20132023. https:\/\/doi.org\/10.1038\/onc.2009.489","journal-title":"Oncogene"},{"issue":"15","key":"4927_CR23","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","volume":"68","author":"K Stemke-Hale","year":"2008","unstructured":"Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF, Pusztai L, Nolden LK, Horlings H, Berns K, Hung MC, van de Vijver MJ, Valero V, Gray JW, Bernards R, Mills GB, Hennessy BT (2008) An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68(15):6084\u20136091. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6854","journal-title":"Cancer Res"},{"issue":"24","key":"4927_CR24","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","volume":"23","author":"NG Iyer","year":"2004","unstructured":"Iyer NG, Ozdag H, Caldas C (2004) p300\/CBP and cancer. Oncogene 23(24):4225\u20134231. https:\/\/doi.org\/10.1038\/sj.onc.1207118","journal-title":"Oncogene"},{"issue":"13","key":"4927_CR25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1101\/gad.14.13.1553","volume":"14","author":"RH Goodman","year":"2000","unstructured":"Goodman RH, Smolik S (2000) CBP\/p300 in cell growth, transformation, and development. Genes Dev 14(13):1553\u20131577","journal-title":"Genes Dev"},{"issue":"16","key":"4927_CR26","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1093\/nar\/gkq184","volume":"38","author":"YF Ramos","year":"2010","unstructured":"Ramos YF, Hestand MS, Verlaan M, Krabbendam E, Ariyurek Y, van Galen M, van Dam H, van Ommen GJ, den Dunnen JT, Zantema A, t Hoen PA (2010) Genome-wide assessment of differential roles for p300 and CBP in transcription regulation. Nucleic Acids Res 38(16):5396\u20135408. https:\/\/doi.org\/10.1093\/nar\/gkq184","journal-title":"Nucleic Acids Res"},{"key":"4927_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.atg.2015.08.002","volume":"6","author":"K Wendelsdorf","year":"2015","unstructured":"Wendelsdorf K, Shah S (2015) Empowered genome community: leveraging a bioinformatics platform as a citizen-scientist collaboration tool. Appl Transl Genom 6:7\u201310. https:\/\/doi.org\/10.1016\/j.atg.2015.08.002","journal-title":"Appl Transl Genom"},{"issue":"7","key":"4927_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073\u20131081. https:\/\/doi.org\/10.1038\/nprot.2009.86","journal-title":"Nat Protoc"},{"issue":"2","key":"4927_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, Land SJ, Lu X, Ruden DM (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6(2):80\u201392. https:\/\/doi.org\/10.4161\/fly.19695","journal-title":"Fly (Austin)"},{"issue":"4","key":"4927_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248\u2013249. https:\/\/doi.org\/10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"issue":"5","key":"4927_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"4","key":"4927_CR32","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1245\/s10434-007-9751-7","volume":"15","author":"YL Lai","year":"2008","unstructured":"Lai YL, Mau BL, Cheng WH, Chen HM, Chiu HH, Tzen CY (2008) PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients. Ann Surg Oncol 15(4):1064\u20131069. https:\/\/doi.org\/10.1245\/s10434-007-9751-7","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"4927_CR33","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1634\/theoncologist.2015-0369","volume":"21","author":"L Santarpia","year":"2016","unstructured":"Santarpia L, Bottai G, Kelly CM, Gyorffy B, Szekely B, Pusztai L (2016) Deciphering and targeting oncogenic mutations and pathways in breast cancer. Oncologist 21(9):1063\u20131078. https:\/\/doi.org\/10.1634\/theoncologist.2015-0369","journal-title":"Oncologist"},{"issue":"3","key":"4927_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.24272\/j.issn.2095-8137.2017.036","volume":"38","author":"WS Zheng","year":"2017","unstructured":"Zheng WS, He YX, Cui CY, Ouzhu L, Deji Q, Peng Y, Bai CJ, Duoji Z, Gongga L, Bian B, Baima K, Pan YY, Qu, Kang M, Ciren Y, Baima Y, Guo W, Yang, Zhang H, Zhang XM, Guo YB, Xu SH, Chen H, Zhao SG, Cai Y, Liu SM, Wu TY, Qi XB, Su B (2017) EP300 contributes to high-altitude adaptation in Tibetans by regulating nitric oxide production. Zool Res 38(3):163\u2013170. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2017.036","journal-title":"Zool Res"},{"issue":"2","key":"4927_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"S Bamford","year":"2004","unstructured":"Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA, Stratton MR, Wooster R (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91(2):355\u2013358. https:\/\/doi.org\/10.1038\/sj.bjc.6601894","journal-title":"Br J Cancer"},{"issue":"21","key":"4927_CR36","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1007\/s00018-012-1254-4","volume":"70","author":"F Wang","year":"2013","unstructured":"Wang F, Marshall CB, Ikura M (2013) Transcriptional\/epigenetic regulator CBP\/p300 in tumorigenesis: structural and functional versatility in target recognition. Cell Mol Life Sci 70(21):3989\u20134008. https:\/\/doi.org\/10.1007\/s00018-012-1254-4","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"4927_CR37","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1046\/j.1432-1327.2001.02226.x","volume":"268","author":"SR Grossman","year":"2001","unstructured":"Grossman SR (2001) p300\/CBP\/p53 interaction and regulation of the p53 response. Eur J Biochem 268(10):2773\u20132778","journal-title":"Eur J Biochem"},{"issue":"3","key":"4927_CR38","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1073\/pnas.97.3.1020","volume":"97","author":"GM Pao","year":"2000","unstructured":"Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM (2000) CBP\/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci USA 97(3):1020\u20131025","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6595","key":"4927_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/383099a0","volume":"383","author":"D Chakravarti","year":"1996","unstructured":"Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM (1996) Role of CBP\/P300 in nuclear receptor signalling. Nature 383(6595):99\u2013103. https:\/\/doi.org\/10.1038\/383099a0","journal-title":"Nature"},{"issue":"3","key":"4927_CR40","doi-asserted-by":"publisher","first-page":"a026534","DOI":"10.1101\/cshperspect.a026534","volume":"7","author":"Narsis Attar","year":"2016","unstructured":"Attar N, Kurdistani SK (2017) Exploitation of EP300 and CREBBP lysine acetyltransferases by cancer. Cold Spring Harb Perspect Med 7 (3). https:\/\/doi.org\/10.1101\/cshperspect.a026534","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"3","key":"4927_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/73536","volume":"24","author":"SA Gayther","year":"2000","unstructured":"Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T, Caldas C (2000) Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24(3):300\u2013303. https:\/\/doi.org\/10.1038\/73536","journal-title":"Nat Genet"},{"issue":"11","key":"4927_CR42","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/carcin\/bgl067","volume":"27","author":"M Wirtenberger","year":"2006","unstructured":"Wirtenberger M, Tchatchou S, Hemminki K, Schmutzhard J, Sutter C, Schmutzler RK, Meindl A, Wappenschmidt B, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B (2006) Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis 27(11):2201\u20132208. https:\/\/doi.org\/10.1093\/carcin\/bgl067","journal-title":"Carcinogenesis"},{"issue":"13","key":"4927_CR43","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1074\/jbc.R115.692020","volume":"291","author":"HJ Dyson","year":"2016","unstructured":"Dyson HJ, Wright PE (2016) Role of intrinsic protein disorder in the function and interactions of the transcriptional coactivators CREB-binding protein (CBP) and p300. J Biol Chem 291(13):6714\u20136722. https:\/\/doi.org\/10.1074\/jbc.R115.692020","journal-title":"J Biol Chem"},{"issue":"17","key":"4927_CR44","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1073\/pnas.0702010104","volume":"104","author":"DP Teufel","year":"2007","unstructured":"Teufel DP, Freund SM, Bycroft M, Fersht AR (2007) Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci USA 104(17):7009\u20137014. https:\/\/doi.org\/10.1073\/pnas.0702010104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"4927_CR45","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1073\/pnas.0811023106","volume":"106","author":"JC Ferreon","year":"2009","unstructured":"Ferreon JC, Lee CW, Arai M, Martinez-Yamout MA, Dyson HJ, Wright PE (2009) Cooperative regulation of p53 by modulation of ternary complex formation with CBP\/p300 and HDM2. Proc Natl Acad Sci USA 106(16):6591\u20136596. https:\/\/doi.org\/10.1073\/pnas.0811023106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4927_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10565-016-9318-0","volume":"32","author":"PD Thomas","year":"2016","unstructured":"Thomas PD, Kahn M (2016) Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation. Cell Biol Toxicol 32(1):61\u201381. https:\/\/doi.org\/10.1007\/s10565-016-9318-0","journal-title":"Cell Biol Toxicol"},{"issue":"52","key":"4927_CR47","doi-asserted-by":"publisher","first-page":"40946","DOI":"10.1074\/jbc.M007832200","volume":"275","author":"LW Yuan","year":"2000","unstructured":"Yuan LW, Gambee JE (2000) Phosphorylation of p300 at serine 89 by protein kinase C. J Biol Chem 275(52):40946\u201340951. https:\/\/doi.org\/10.1074\/jbc.M007832200","journal-title":"J Biol Chem"},{"issue":"15","key":"4927_CR48","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1128\/MCB.25.15.6592-6602.2005","volume":"25","author":"WC Huang","year":"2005","unstructured":"Huang WC, Chen CC (2005) Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25(15):6592\u20136602. https:\/\/doi.org\/10.1128\/MCB.25.15.6592-6602.2005","journal-title":"Mol Cell Biol"},{"issue":"9","key":"4927_CR49","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrc2211","volume":"7","author":"KA Green","year":"2007","unstructured":"Green KA, Carroll JS (2007) Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer 7(9):713\u2013722. https:\/\/doi.org\/10.1038\/nrc2211","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"4927_CR50","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S0966-842X(00)01874-6","volume":"8","author":"MO Hottiger","year":"2000","unstructured":"Hottiger MO, Nabel GJ (2000) Viral replication and the coactivators p300 and CBP. Trends Microbiol 8(12):560\u2013565","journal-title":"Trends Microbiol"},{"issue":"32","key":"4927_CR51","doi-asserted-by":"publisher","first-page":"13260","DOI":"10.1073\/pnas.0906770106","volume":"106","author":"JC Ferreon","year":"2009","unstructured":"Ferreon JC, Martinez-Yamout MA, Dyson HJ, Wright PE (2009) Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc Natl Acad Sci USA 106(32):13260\u201313265. https:\/\/doi.org\/10.1073\/pnas.0906770106","journal-title":"Proc Natl Acad Sci USA"},{"key":"4927_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2017.04.013","author":"A Rahbar","year":"2017","unstructured":"Rahbar A, Touma J, Costa H, Davoudi B, Bukholm IR, Sauer T, Vetvik K, Geisler J, Soderberg-Naucler C (2017) Low expression of estrogen receptor-alpha and progesterone receptor in human breast cancer tissues is associated with high-grade human cytomegalovirus protein expression. Clin Breast Cancer. https:\/\/doi.org\/10.1016\/j.clbc.2017.04.013","journal-title":"Clin Breast Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4927-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4927-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4927-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T22:05:36Z","timestamp":1661810736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4927-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["4927"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4927-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"14 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}